Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,523,966
-$714,630 QoQ
Shares Held
116,416
-4.9% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
5.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Panoramic Capital, LLC holds $8,929,966 across 2 Biotechnology names. HALO ranks #1 (84.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
116,416 | $7,523,966 | |
| 2 | NRXS |
Neuraxis, INC
|
190,000 | $1,406,000 |
All Filings in HALO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,523,966 | 116,416 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,238,596 | 122,416 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,558,502 | 89,426 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,681,800 | 90,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,630,621 | 135,255 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,620,992 | 54,821 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||